241 related articles for article (PubMed ID: 1602891)
1. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
2. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
3. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
4. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
5. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
7. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
8. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
9. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
11. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
13. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
Leonardi S; La Spina M; La Rosa M; Schilirò G
Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
16. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
18. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
[TBL] [Abstract][Full Text] [Related]
19. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
20. [The significance of aminoterminal procollagen type-III peptide in chronic hepatopathies].
Caballería J
Med Clin (Barc); 1992 May; 99(1):21-3. PubMed ID: 1602894
[No Abstract] [Full Text] [Related]
[Next] [New Search]
